The K9-Map is a structured representation of the nine key clusters of decision-related problems that determine the value of a medical technology venture. It is built through a reverse, value-driven logic: starting from the venture’s value, linking it to cash flow, and then tracing back the underlying decisions that shape both pre-market and post-market outcomes. This construction highlights that the most critical uncertainties are not only technical, but also commercial, clinical, and financial—especially those affecting future revenues.
The role of the K9-Map is to guide decision-making under uncertainty. It provides a coherent sequence that helps prioritize which problems must be addressed first, ensuring that effort and capital are directed toward the most value-critical questions. By making dependencies explicit, it reduces the risk of fragmented or misaligned decisions.
For medical technology entrepreneurs, the K9-Map offers a disciplined way to structure development and de-risk innovation. For investors, it provides a transparent framework to assess where value is created, where risks remain, and how effectively they are being managed. In both cases, it enables more rational, evidence-based decisions in an inherently uncertain environment.